XML 43 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Narrative) (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2021
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Feb. 16, 2021
Feb. 09, 2021
USD ($)
Summary Of Significant Accounting Policies [Line Items]                  
Continuation Advances       $ 34,000 $ 18,000        
Period in which company must repay continuation advances if change-of-control transaction is entered into with third party           2 years      
Equity or debt financing that must be raised in a single transaction           $ 100,000      
Contingent repayment liability   $ 168,574       168,574      
Gain (loss) from Continuation Advances           $ (52,000) $ 34,000    
Continuation Advances paid $ 52,000                
Sales Revenue, Net [Member] | Gene Company Limited [Member] | Customer Concentration Risk [Member]                  
Summary Of Significant Accounting Policies [Line Items]                  
Concentration risk, percentage   17.00% 18.00%     15.00% 14.00%    
Minimum [Member] | Measurement Input, Discount Rate [Member]                  
Summary Of Significant Accounting Policies [Line Items]                  
Debt Instrument, Measurement Input   0.043       0.043      
Maximum [Member] | Measurement Input, Discount Rate [Member]                  
Summary Of Significant Accounting Policies [Line Items]                  
Debt Instrument, Measurement Input   0.048       0.048      
Convertible Senior Notes [Member]                  
Summary Of Significant Accounting Policies [Line Items]                  
Principal amount of notes $ 900,000               $ 900,000
Debt instrument, stated interest rate 1.50%             1.50%  
Maturity date           Feb. 15, 2028